Wilbur Ross (Trades, Portfolio) is the founder of WL Ross & Co. LLC, an investment firm that turns around distressed assets. Founded in 2000 with $440 million in startup funds, it now has over $7 billion in assets under management. Ross’ current investment themes are: energy, financial services, health care, heavy materials and transportation.
Ross’ stock portfolio contains nine stocks with a value of $866 million. The preponderance of it is invested in a single stock, Navigator Holdings (NVGS, Financial), at 53.2%. He also expressed interest in European opportunities last week and became vice chairman of Bank of Cyprus (ATH:BOC, Financial) in November.
In the fourth quarter, Ross sold out of two positions and replaced them with two others, from the U.S. and Canada: Xenon Pharmaceuticals Inc. (XENE, Financial) and Inphi Corp (IPHI, Financial).
Xenon Pharmaceuticals Inc. (XENE, Financial)
Ross purchased 444,655 shares of Xenon Pharmaceuticals Inc., representing 1% of the portfolio. The fourth quarter’s average price per share was $15.
Xenon Pharmaceuticals Inc. was incorporated in the Province of British Columbia on Nov. 5, 1996. Xenon Pharmaceuticals Inc. has a market cap of $280.9 million; its shares were traded at around $19.80 with a P/E ratio of 16.6 and P/S ratio of 7.0.
Ross bought 71,424 shares of Inphi Corp, a 0.15% portfolio position. The company’s share price averaged $15 in the quarter.
Inphi Corp was incorporated in Delaware in November 2000 as TCom Communications Inc. Inphi Corp has a market cap of $684.4 million; its shares were traded at around $18.45 with and P/S ratio of 4.40.
See more Wilbur Ross (Trades, Portfolio) stocks at his portfolio here. Not a Premium Member of GuruFocus? Try it free for 7 days here.
